CSIMarket
 


Quest Patent Research Corp  (QPRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quest Patent Research's Working Capital Ratio

QPRC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




QPRC Working Capital Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Current Liabilities Change 20.14 % 34.25 % 63.62 % 47.44 % 55.1 %
Y / Y Current Assets Change 24.32 % 346.15 % 1320.8 % 1848.57 % 3469.96 %
Working Capital Ratio MRQ 0.1 0.06 0.25 0.12 0.09
Overall Ranking # # # # #
Seq. Current Liabilities Change 1.73 % -7.96 % 25.88 % 1.93 % 13.68 %
Seq. Current Assets Change 54.78 % -76.45 % 170.47 % 26.07 % 455.47 %



Working Capital Ratio second quarter 2020 Comment
Quest Patent Research's Current Assets grew by 54.78 % in II. Quarter sequntially, faster than Current Liabilities, this led to improvement in Quest Patent Research's Working Capital Ratio to 0.1, Working Capital Ratio remained below Quest Patent Research Corp average.

Within Biotechnology & Drugs industry 201 other companies have achieved higher Working Capital Ratio than Quest Patent Research in second quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is QPRC most successful ?
Working Capital Ratio QPRC on the trailing twelve month basis
Working Capital Ratio second quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 202
Healthcare Sector # 800
Overall Market # 4370


Working Capital Ratio Statistics
High Average Low
0.81 0.12 0
(Dec 31 2015)   (Jun 30 2018)




Financial Statements
Quest Patent Research's Current Liabilities $ 9 Millions Visit QPRC's Balance sheet
Quest Patent Research's Current Assets $ 1 Millions Visit QPRC's Balance sheet
Source of QPRC's Sales Visit QPRC's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingJun 30 2020, within Biotechnology & Drugs Industry Working Capital RatioJun 30 2020 MRQ Current AssetsJun 30 2020 MRQ Current Liabilities
Azurrx Biopharma Inc   0.21 $ 1.637  Millions$ 7.616  Millions
Gtx Corp  0.19 $ 0.658  Millions$ 3.457  Millions
Cell Medx Corp   0.17 $ 0.157  Millions$ 0.943  Millions
Cardax Inc   0.14 $ 1.294  Millions$ 9.152  Millions
Twinlab Consolidated Holdings Inc   0.14 $ 17.103  Millions$ 124.048  Millions
Guided Therapeutics Inc  0.10 $ 0.855  Millions$ 8.630  Millions
Quest Patent Research Corp  0.10 $ 0.877  Millions$ 8.937  Millions
Mateon Therapeutics Inc  0.10 $ 0.783  Millions$ 8.217  Millions
Therapeutic Solutions International Inc   0.09 $ 0.190  Millions$ 2.033  Millions
Cannabis Global Inc   0.06 $ 0.169  Millions$ 2.822  Millions
Burzynski Research Institute Inc  0.04 $ 0.009  Millions$ 0.255  Millions
Gt Biopharma Inc   0.03 $ 0.971  Millions$ 28.562  Millions
Qrons Inc   0.02 $ 0.016  Millions$ 0.681  Millions
Skinvisible Inc   0.02 $ 0.056  Millions$ 2.365  Millions
Mymetics Corp  0.02 $ 1.514  Millions$ 68.769  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VITL's Profile

Stock Price

VITL's Financials

Business Description

Fundamentals

Charts & Quotes

VITL's News

Suppliers

VITL's Competitors

Customers & Markets

Economic Indicators

VITL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071